Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Prevention and Control of Non-Communicable Diseases in Iran: The Case for Investment Publisher Pubmed



Yousefi M1 ; Dastan I2 ; Alinezhad F3 ; Ranjbar M4 ; Hamelmann C5 ; Ostovar A6 ; Moghisi A7 ; Mohammadi S8 ; Mataria A9 ; Hammerich A10 ; Slama S11 ; Pourghazian N11 ; Hezaveh AM12 ; Valizadeh B13 Show All Authors
Authors
  1. Yousefi M1
  2. Dastan I2
  3. Alinezhad F3
  4. Ranjbar M4
  5. Hamelmann C5
  6. Ostovar A6
  7. Moghisi A7
  8. Mohammadi S8
  9. Mataria A9
  10. Hammerich A10
  11. Slama S11
  12. Pourghazian N11
  13. Hezaveh AM12
  14. Valizadeh B13
  15. Torabi P14
  16. Najmi M15
  17. Moradi M16
  18. Hodjatzadeh A16
  19. Keshvarishad F1
Show Affiliations
Authors Affiliations
  1. 1. Department of Health Economics, School of Management and Medical Informatics, Tabriz University of Medical Sciences, Tabriz, Iran
  2. 2. Health Policy, WHO Country Office, Dushanbe, Tajikistan
  3. 3. Bouve Colleage of Health Sciences, Northeastern University, Boston, MA, United States
  4. 4. National Professional Officer, NCD and Mental Health Unit Head, WHO, Tehran, Iran
  5. 5. World Health Organization Representative in I.R.Iran, WHO, Tehran, Iran
  6. 6. Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran
  7. 7. Deputy General Director for NCD Management Office, Ministry of Health and Medical Education, IR, Tehran, Iran
  8. 8. Islamic Azad University, Tehran, Iran
  9. 9. Universal Health Coverage/Health Systems (UHS), World health Organization, Regional Office for Eastern Mediterranean (WHO-EMRO), Cairo, Egypt
  10. 10. UHC/NCDs, World Health Organization, Regional Office for Eastern Mediterranean (WHO-EMRO), Cairo, Egypt
  11. 11. Non Communicable Diseases Prevention (NCP), UHC/NCDs, World Health Organization, Regional Office for Eastern Mediterranean (WHO-EMRO), Cairo, Egypt
  12. 12. Cardio Vascular Diseases Prevention Department, NCD Management Office, Ministry of Health and Medical Education, IR, Tehran, Iran
  13. 13. National Tobacco Control Secretariat, Ministry of Health and Medical Education, IR, Tehran, Iran
  14. 14. National Manager of Clinical Nutrition Group, Ministry of Health and Medical Education, IR, Tehran, Iran
  15. 15. Director of Respiratory Diseases Prevention Department, NCD Management Office, Ministry of Health and Medical Education, IR, Tehran, Iran
  16. 16. Expert of Cardio Vascular Diseases Prevention Department, NCD Management Office, Ministry of Health and Medical Education, IR, Tehran, Iran

Source: BMC Public Health Published:2022


Abstract

Background: Non-communicable diseases are imposing a considerable burden on Iran. This study aims to assess the Return on Investment (ROI) for implementation of Non-communicable diseases (NCDs) prevention program in Iran. Methods: Four disease groups including cardiovascular diseases, diabetes, cancer, and respiratory diseases were included in our ROI analysis. The study followed four steps: 1) Estimating the total economic burden of NCDs using the Cost-of-Illness approach. 2) Estimating the total costs of implementing clinical and preventive interventions using an ingredient based costing at delivering level and a program costing method at central level.3) Calculating health impacts and economic benefits of interventions using the impact measures of avoided incidence, avoided mortality, healthy life years (HLYs) gained, and avoided direct treatment costs. 4) Calculating the ROI for each intervention in 5- and 15- year time horizons. Results: The total economic burden of NCDs to the Iranian economy was IRR 838.49 trillion per year (2018), which was equivalent to 5% of the country’s annual Gross Domestic Product (GDP). The package of NCD will lead to 549 000 deaths averted and 2 370 000 healthy life years gained over 15 years, and, financially, Iranian economy will gain IRR 542.22 trillion over 15 years. The highest ROI was observed for the package of physical activity interventions, followed by the interventions addressing salt, tobacco package and clinical interventions. Conclusions NCDs in Iran are causing a surge in health care costs and are contributing to reduced productivity. Those actions to prevent NCDs in Iran, as well as yielding to a notable health impact, are giving a good economic return to the society. This study underscores an essential need for establishment of a national multi-sectorial NCD coordination mechanism to bring together and strengthen existing cross-agency initiatives on NCDs. © 2022, The Author(s).